ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,527.20
      1.07%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,918.18
      3.24%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Avenue Therapeutics Inc (ATXI)

      7. Avenue Therapeutics Inc (ATXI) Financials

      Avenue Therapeutics Inc

      Avenue Therapeutics Inc (ATXI)

      NASDAQ
      2.72
      -0.15
      (-5.23%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      2.72
      0.00
      ( 0.00% )
      After Hours: 6:56PM
      Delayed by 15 minutes

      Avenue Therapeutics Inc Financial Summary

      The current ATXI market cap is 2.56M. The company's latest EPS is USD -11.0278 and P/E is -0.24.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.43M-3.92M-2.07M-2.12M-3.71M
      Net Income -7.54M-4.01M526k640k-4.34M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -26.27M-5.21M-3.74M-8.04M-14.54M
      Net Income -25.91M-5.15M-3.73M-3.55M-10.38M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.45M1.67M502k1.85M3.31M
      Total Liabilities 10.6M7.81M5.02M1.2M1.41M
      Total Equity -2.16M-6.15M-4.52M654k1.9M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.92M3.25M3.96M6.85M1.85M
      Total Liabilities 2.12M886k509k3.58M1.2M
      Total Equity 6.8M2.36M3.45M3.27M654k

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -1.57M-6.24M-7.13M-9.45M-3.12M
      Investing N/A -2M-3M-3M N/A
      Financing 3.1M3.1M3.58M7.53M4.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.26M-4.61M-3.75M-7.6M-9.45M
      Investing N/A -1M N/A N/A -3M
      Financing 32.33M N/A 4.38M10.54M7.53M

      Stats and Ratios

      Market Cap 2.56M
      Price to Earnings Ratio -0.24
      Price to Sales Ratio 0
      Price to Cash Ratio 1.39
      Price to Book Ratio 3.8
      Dividend Yield -

      Share Statistics

      Shares Outstanding 940.99k
      Average Volume (1 week) 217.55k
      Average Volume (1 Month) 81.67k
      52 Week Change -96.70%
      52 Week High 87.00
      52 Week Low 2.60
      Spread (Intraday) 0.4 (12.9%)

      Company Info

      Company Name Avenue Therapeutics Inc
      Address 3500 s dupont hwy
      dover, delaware 19901
      Website https://www.avenuetx.com
      Industry pharmaceutical preparations (2834)